Women Suing over Defective Fertility Drug

Comments (0)

A number of women in the U.S. are currently suing Ferring Pharmaceuticals, which manufactured Bravelle, a fertility drug. The drug was later found to be ineffective, and the company recalled it in 2015 voluntarily. However, after the recall, the company offered to compensate women who took the drug for the cost of the medication only. Many women felt that compensation was not enough, and instead sued the company.

Bravelle is an injectable medication that provided hormones necessary to help women’s ovaries produce eggs. The drug was approved by the FDA in 2002, but the company got many complaints about its effectiveness. Many women claimed that the drug failed to make them fertile at all. The FDA announced that the drug did not have enough of the active ingredient to allow women to become pregnant. In some cases, the women did not get the benefits of the drug, but they were exposed to the side effects of the drug.

The women who took Bravelle say that receiving a refund for the medication is not enough to compensate them. They say that they had additional medical procedures and treatments performed in connection with the drug, including expensive fertility treatments.

Several class action lawsuits have been filed, seeking compensation for women who took the drug. The lawsuits are asking for a full refund of all expenses, in addition to pain and suffering. If you took Bravelle and you are interested in learning more about how to join a class action lawsuit, call the attorneys at Kennedy Hodges. They can help. Call today to learn more or to schedule a free consultation on your case at 855-947-0707. 

Be the first to comment!

Post a Comment

To reply to this message, enter your reply in the box labeled "Message", hit "Post Message."


Email:* (will not be published)


Notify me of follow-up comments via email.